Dynamic contrast-enhanced computed tomography to assess early activity of cetuximab in squamous cell carcinoma of the head and neck

BACKGROUND: Cetuximab, a monoclonal antibody targeting the Epidermal Growth Factor Receptor (EGFR), has demonstrated activity in various tumor types. Using dynamic contrast-enhanced computed tomography (DCE-CT), we investigated the early activity of cetuximab monotherapy in previously untreated pati...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Radiol Oncol
Autors principals: Schmitz, Sandra, Rommel, Denis, Michoux, Nicolas, Lhommel, Renaud, Hanin, François-Xavier, Duprez, Thierry, Machiels, Jean-Pascal
Format: Artigo
Idioma:Inglês
Publicat: Versita, Warsaw 2015
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4362602/
https://ncbi.nlm.nih.gov/pubmed/25810697
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2478/raon-2014-0030
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars